Carbon nanotubes activate inflammatory signalling through binding to Siglec-14
Crossref DOI link: https://doi.org/10.1038/s41565-023-01420-4
Published Online: 2023-06-14
Published Print: 2023-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Greene, Michelle K.
Scott, Christopher J. http://orcid.org/0000-0002-7582-3808
Text and Data Mining valid from 2023-06-01
Version of Record valid from 2023-06-01
Article History
First Online: 14 June 2023
Competing interests
: M.K.G. and C.J.S. own shares in Aviceda Therapeutics and Avilect Biosciences.